Dates: Thursday, April 11-13, 2024 Location: The Rockefeller University, New York, USA
Overview: The Henry Kunkel Society (HKS) meeting is an annual gathering of leading immunologists, researchers, clinicians, and trainees from around the world. Established to honor the life and legacy renowned immunologist Dr. Henry G. Kunkel, this event provides a platform for the exchange of groundbreaking research and the latest advancements in the field of immunology.
The 2024 HKS Meeting signifies the 31st annual gathering of the society, the eighth collaboration with the Journal of Experimental Medicine (JEM), and the fourth partnership with the Rockefeller University Friday Lecture Series (FLS). This meeting centers around the theme "The Thymus: Navigating the Nexus of Biology and Medicine." Dr. Mark S. Anderson, PhD, of University of California, San Francisco is the meeting chair.
We are honored to announce that Dr. Christopher Goodnow, PhD from the Garvan Institute of Medical Research in Australia will be delivering the keynote address.
Speakers Include:
Nuno Alves, PhD, University of Porto, Porto, Portugal
Graham Anderson, PhD, University of Birmingham, Birmingham, UK
Mark S. Anderson, MD, PhD, University of California San Francisco, CA, USA
Vivien Béziat, PhD, INSERM, Paris Cité University, Paris, France
Thomas Boehm, PhD, Max Planck Institute, Freiburg, Germany
Marita Bosticardo, PhD, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA
Marina Cavazzana, MD, PhD, Necker Hospital for Sick Children, Paris, France
Gay M. Crooks, MD, University of California Los Angeles, Los Angeles, CA, USA
Stephen Daley, PhD, Monash University, Victoria, Australia
Mark M. Davis, PhD, Stanford University School of Medicine & Howard Hughes Medical Institute, Stanford, CA, USA
Sarah S. Dinges, MD, Charité – Berlin University of Medicine, Berlin, Germany
Ronald Germain, MD, PhD, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA
Alexandra Y. Kreins, MD, PhD, University College London, London, UK
Tom Le Voyer, MD, PhD, Necker Hospital for Sick Children, Paris, France
Michail Lionakis, MD, ScD, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA
Diane Mathis, PhD, Harvard Medical School, Boston, MA, USA
Audrey Parent, PhD, University of California San Francisco, CA, USA
Ellen A. Robey, PhD, University of California at Berkeley, Berkeley, CA, USA
Ellen V. Rothenberg, PhD, California Institute of Technology, Pasadena, CA, USA
Alexander Rudensky, PhD, Memorial Sloan Kettering Cancer Center & Howard Hughes Medical Institute, New York, NY, USA
John W. Sleasman, MD, Duke University, Durham, NC, USA
Tom Taghon, PhD, Ghent University, Ghent, Belgium
Nicolai Van Oers, PhD, The University of Texas Southwestern Medical Center, Dallas, TX, USA
Anna Villa, MD, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy
Michael Waterfield, MD, PhD, University of California San Francisco, CA, USA
Peter Zandstra, PhD, University of British Columbia, Vancouver, Canada
Leonard I. Zon, MD, Harvard Medical School, Boston, MA, USA
Juan Carlos Zúñiga-Pflücker, PhD, Sunnybrook Research Institute, Toronto, Canada
